Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Bronchitis is the inflammation in the bronchi of the lungs caused due to viral infections. This is a condition where the bronchial tubes are lined with infection causing constricted airways. This results in reduced ability to breathe. This condition usually is preceded by a cold or a viral infection. Bronchitis also called as laryngotracheobronchitis is characterized into acute and chronic bronchitis.
Acute bronchitis is a temporary condition that may last for up to 3 weeks characterized by cough with mucus, discomfort in the chest and shortness of breath and fever. The general causal agents of this type of bronchitis are viruses such as the fly or common cold, smoke, dust, fumes or irritable vapours. Chronic bronchitis is serious illness caused due to environmental factors or cigarette smoking. It is often characterized by cough with thick mucus that lasts up to 3 months with varying difficulties in breathing. This condition may also lead to chronic obstructive pulmonary disease (COPD) and emphysema. The causal agents of chronic bronchitis are repeated exposure to lung irritants, smoking, exposure to severe air pollution caused by industrial vapours, advancing age and passive smoking.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Bronchitis is a disease if untreated can lead to severe health complications like pneumonia, COPD and death risks in adults. There were a total of 6.8 million people diagnosed of Obstructive pulmonary disease in the past year. The number of people estimated to be diagnosed of COPD by the next year is 43 million. About 300,000 people attended the emergency respiratory care for bronchitis in the previous year and the average number of days they were admitted in the hospitals was 4-5 days. Please who have died of other respiratory tract diseases and chronic lower respiratory diseases is estimated at 140,000.
An inflammation of the mucous membranes of the bronchi is known as Bronchitis. The disease can be divided into two categories: acute and chronic. The development of a cough or small sensation in the back of the throat which can be with or without the production of sputum is characteristic feature of acute bronchitis (mucus that is expectorated, or "coughed up", from the respiratory tract). It often occurs during the course of an acute viral illness such as the common cold or influenza. It has been seen in the research that about 90 % casual organism of acute bronchitis are viruses and about 10 % are bacteria. Simple measures such as taking plenty of rest, consumption of large amount of liquids, prevent you from smoking and if possible getting a prescription for an inhaled bronchodilator or cough syrup constitutes conventional treatment for acute bronchitis. However in some cases of chronic bronchitis, oral steroids to reduce inflammation and/or supplemental oxygen may be necessary. It has been seen that in healthy people with bronchitis who have normal lungs and no chronic health problems, there is no need of antibiotics. In case if the casual organism is virus, antibiotic will not have any significant effect on it. It might possible that a productive (phlegm-producing) cough may come with acute bronchitis. However this is your body's way of getting rid of excess mucus. But if your cough is truly disruptive it will keep you away from sleeping. But in maximum cases you should simply do all the things you usually would do for a cold which may include taking of aspirin or acetaminophen for discomfort and drink lots of liquids. We should not give aspirin to a child aged 18 years of age or younger because of the increased risk of Reye’s syndrome.
The global markets for chronic bronchitis have been on a fall as estimated by specialists. The global bronchitis market was valued at $5,984m in 2010 and the estimated value for the end of the decade is around $6,931m. The rate of increase was found to be at 1.9%, while the same for the previous decade was around 13%. The novel products released during the previous decade seem to be reasons for the increase in the market value. The number of drugs in their third phase trials is estimated to increase the market value for respiratory diseases.
The United Kingdom respiratory care market, based on anatomical features, the respiratory system is segmented into upper respiratory tract and lower respiratory tract. The upper respiratory tract comprises pharynx, larynx, and nasal passages, while the lower respiratory tract includes trachea, lungs, and bronchi. Respiratory disease is a medical condition that affects the structure and organs associated with respiration or breathing. Equipment used to detect pulmonary abnormalities hold immense potential due to increasing prevalence of various respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, and pneumonia. Moreover, growing geriatric population and technological advancements would drive the global respiratory disease testing market. However, low adoption rate of digital radiography and portable spirometers are projected to hold back the growth of respiratory disease testing market from 2014 to 2022. The global respiratory disease testing market was valued at USD 2,326.5 million in 2013 and is estimated to reach USD 3,143.3 million in 2022, expanding at a CAGR of 3.4% from 2014 to 2022. For instance, the Centers for Disease Control and Prevention (CDC) published in 2012 that around 18.7 million adults in the U.K. were suffering from asthma. The American Lung Association states that COPD is the third leading cause of death in the U.K.
3rd COPD conference <br>July 11-12, 2016 Brisbane, Australia
2nd Infectious Diseases Conference: <br>August 25-27, 2016 Philadelphia, USA
Global Influenza Conferences <br>August 24-26, 2015 West Drayton, London, UK
4th Immunology Conference <br>September 28-30, 2015 Houston, Texas, USA
2nd Flu Conference <br>November 17-19, 2016 San Francisco, USA
Indian Chest Society and Chest Physicians 17th Joint National Conference
November 4-7, 2015, Jaipur, India.
11th Respiratory Diseases conference
October 8-11, 2015, Chengdu, India
CHEST 2015 Conference:
October 24-28, Canada
46th Lung Health Conference, Cape Town, South Africa,
Dec: 2-6, 2015
20th Congress of the Asia Pacific Society of Respirology, Malaysia,
5th TB and Lung Disease Conference - Asia Pacific Region:
Aug-31, Sep- 2, 2015, Sydney
Respiratory Pathogens Conference:
Sep 2-4, 2015, Singapore
Respiratory Diseases Conference:
Sep3-6, Guiyang City
Respiratory Care Indonesia:
Sep2-4, Shangri-La Hotel
16th Lung Cancer Conference:
September 6 - 9 2015 Colorado, USA
European Respiratory Society International Congress:
26 September 2015, Amsterdam
Relevant Societies and Associations:
Cambridge Development Initiative
Cambridge Graduate Course in Medicine Society
Cambridge Romanian Society
Research Drones Society, Oxford
Midland Geotechnical Society – UK
Palaeontological Association – UK
The British Hospitality Association
National Housing Federation
Self-Storage Association UK
Vietnam Respiratory Society
Lung Health UK
British Lung Foundation
British Thoracic Society
British Association for Lung Research
The Sarcoidosis charity
The Freeman Heart & Lung Transplant Association
British Snoring and Sleep Apnoea Association
Association of Respiratory Nurses (ARNS)
Association of charted Physiotherapists in respiratory care (ACPRC)
List of Companies and retreat Centers:
Merk & Co
Johnson & Johnson
British American Tobacco
Imperial Tobacco Group
Reckitt Benckiser Group
Acm Global Central Laboratory Services Ltd
Acorn Polymers (U K ) Ltd
Access Health Products
Acm Global Central Laboratory Services Ltd
Acorn Equipment Co Ltd
Advanced Healthcare Ltd
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising